| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/02/2008 | EP1210082B1 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 01/02/2008 | EP1169036B1 Anti-viral uses of leflunomide products |
| 01/02/2008 | EP1129177B1 Avipox vector coding an hiv antigen and gamma-interferon |
| 01/02/2008 | EP1005365B1 Epitopes of an extracellular antigen |
| 01/02/2008 | EP0722499B1 Immunoreactive antigens of hepatitis e virus |
| 01/02/2008 | CN101098958A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 01/02/2008 | CN101098881A Macrolones - amino substituted quinolones |
| 01/02/2008 | CN101098860A Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 01/02/2008 | CN101096686A Recombined chicken poxviral active carrier vaccine rFPV-1218NDHN for expression of newcastle disease virus HN gene and its constructing method |
| 01/02/2008 | CN101096685A Recombined chicken poxviral active carrier vaccine rFPV-1218NDF for expression of newcastle disease virus F gene and its constructing method |
| 01/02/2008 | CN101096382A Aglyco products and methods of use |
| 01/02/2008 | CN101096370A Valine entecavir and preparation method and application |
| 01/02/2008 | CN101096369A Oxazolidinone compound containing thiadiazoles groups and preparation method thereof |
| 01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/02/2008 | CN101095952A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies |
| 01/02/2008 | CN101095951A Therapeutic HBV DNA vaccines, method for preparing the same and application thereof |
| 01/02/2008 | CN101095950A Hydrophobia vaccine freezing drying preparations for stable human beings and the preparations thereof |
| 01/02/2008 | CN101095949A Shigellae oil-emulsion inactivated vaccine and the developing method thereof |
| 01/02/2008 | CN101095915A Chinese traditional medicine for treating diabetes cholecystitis |
| 01/02/2008 | CN101095885A Chinese traditional medicine for treating myocarditis |
| 01/02/2008 | CN101095879A Chinese traditional medicine for treating tuberculosis disease and the confecting method thereof |
| 01/02/2008 | CN101095869A Medicine for treating AIDS |
| 01/02/2008 | CN101095851A Chinese traditional medicine soup composition and method of making the same |
| 01/02/2008 | CN101095821A Chinese traditional medicine preparations for treating diabetes erysipelas |
| 01/02/2008 | CN101095746A Cold treating medicine composition and method of making the same and the use thereof |
| 01/02/2008 | CN101095707A Use of bupleurum root total polyoses in the preparing of medicine for preventing and treating acute respiratory distress syndrome |
| 01/02/2008 | CN101095696A Powder preparation for treating zoster |
| 01/02/2008 | CN101095678A Application of sophocarpine and the medicine salt thereof in the preparing of the medicine for improving immune function |
| 01/02/2008 | CN101095677A Application of sophocarpine and the medicine salt thereof in the preparing of the medicine for increasing interferon |
| 01/02/2008 | CN101095670A Luteolin phospholipid complexes and method for preparing the same and application thereof |
| 01/02/2008 | CN101095667A Liquid for disinfecting wound and the disinfecting method thereof |
| 01/02/2008 | CN101095664A Phosphatide compound of resveratrol compounds and method for preparing the same and the application thereof |
| 01/02/2008 | CN101095659A Liposome combined medicine and method for preparing the same |
| 01/02/2008 | CN100359327C Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 01/02/2008 | CN100359004C Natural killer cell for transgenic expression cell chemotactic factors |
| 01/02/2008 | CN100358901C Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
| 01/02/2008 | CN100358891C Pyranones useful as ATM inhibitors |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/02/2008 | CN100358861C Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 01/02/2008 | CN100358579C Compositions and methods to improve oral absorption of antimicrobial agents |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/02/2008 | CN100358554C Chinese medicinal capsules for disinfecting and relieving toxicity and their preparation |
| 01/02/2008 | CN100358547C Tinea cruris ointment |
| 01/02/2008 | CN100358537C Compound povidone iodine external use medicine |
| 01/02/2008 | CN100358534C Use of malposed double-strauded oligo nucleotide for preparing medicine for treating avian flu virus infection |
| 01/02/2008 | CN100358531C Glycyrrhizin drop pills and preparation method thereof |
| 01/02/2008 | CN100358523C Preparation method of paracetamol pseudoephedrine hydrochloride and cholrphenamine maleate oral disintegration tablet |
| 01/02/2008 | CN100358522C Anti-beta-lactamase antibiotic composite preparation |
| 01/02/2008 | CN100358518C Pharmaceutical compositions containing terbinafin and use thereof |
| 01/02/2008 | CN100358516C Application of rugose soft sulfo-acid in anti HIV-1 virus |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314923 The present invention relates to novel oligonucleotide analogues, which exhibit antisense or antigene activity having excellent stability, or exhibit excellent activity as a detection agent (probe) for a specific gene or as a primer |
| 01/01/2008 | US7314919 Human recombinant antibody against the hepatitis C (HCV) non structural NS3 protein nucleic acid and uses thereof |
| 01/01/2008 | US7314910 In situ diagnosis, detection of antibodies, immunogenic formulations |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
| 01/01/2008 | US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 01/01/2008 | US7314857 Synergistic antimicrobial compositions and methods of inhibiting biofilm formation |
| 01/01/2008 | US7314731 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents |
| 01/01/2008 | US7314642 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 01/01/2008 | US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |
| 01/01/2008 | US7314629 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection |
| 01/01/2008 | US7314626 Peptide antibiotic conjugate for use in recognition and elimination of infections agents or neoplasms; antitumor agents; bactericides |
| 01/01/2008 | US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells |
| 12/30/2007 | CA2592727A1 Nanoparticulate and controlled release compositions comprising a cephalosporin |
| 12/27/2007 | WO2007150002A2 PRODRUGS OF 5-AMINO-3-(3'-DEOXY-β-D-RIBOFURANOSYL)-THIAZOLO[4,5-d] PYRIMIDIN-2,7-DIONE |
| 12/27/2007 | WO2007149891A2 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 12/27/2007 | WO2007149557A1 FUSED [d]PYRIDAZIN-7-ONES |
| 12/27/2007 | WO2007149052A1 Novel polypeptides for anti-viral treatment |
| 12/27/2007 | WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 12/27/2007 | WO2007149012A1 Live tularemic vaccine nik-sp.f. tularensis |
| 12/27/2007 | WO2007148780A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor |
| 12/27/2007 | WO2007148714A1 Implant using rifamycin derivative |
| 12/27/2007 | WO2007148713A1 Drug for treating vascular disease or drug for controlling cell proliferation comprising rifamycin derivative as the active ingredient |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007148488A1 Peptide for reactivation of inactivated gene |
| 12/27/2007 | WO2007148135A1 Macrocyclic compounds as antiviral agents |
| 12/27/2007 | WO2007148093A1 Antibacterial compositions |
| 12/27/2007 | WO2007147884A1 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 12/27/2007 | WO2007147794A1 Furan derivatives and their use as antiviral agents |
| 12/27/2007 | WO2007147623A2 A novel target in the treatment of cytokine release syndrome |
| 12/27/2007 | WO2007147401A1 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents |
| 12/27/2007 | WO2007147336A1 Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents |
| 12/27/2007 | WO2007147297A1 The use of derviate of pyridone for preventing and treating radioactive injury of lungs |
| 12/27/2007 | WO2007147255A1 Synthetic monodisperse hemozoin crystals preparation and uses thereof |
| 12/27/2007 | WO2007092558A3 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 12/27/2007 | WO2007079389A3 Composition and method of use thereof |
| 12/27/2007 | WO2006129158B1 3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i |
| 12/27/2007 | WO2006112694A8 Nutritional supplement with colostrum and epa or dha or gla |
| 12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
| 12/27/2007 | US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders |
| 12/27/2007 | US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 12/27/2007 | US20070299106 Novel mycobacterial inhibitors |
| 12/27/2007 | US20070299078 Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors |